IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in IDEAYA Biosciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 204
- +47 vs. Q4 2023
- Shares held
- 79.1M
- +12.9M (+19.6%) vs. Q4 2023
- Total value
- $3.47B
- +$1.12B (+47.4%) vs. Q4 2023
- New holders
- 59
- 78 more added
- Sold out
- 12
- 52 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 4,155,757 | $182.4M | 0.00% | +679,985+19.6% | Added |
| Federated Hermes, Inc. | 4,856,078 | $213.1M | 0.49% | +972,303+25.0% | Added |
| BlackRock Inc. | 5,965,413 | $261.8M | 0.01% | +528,745+9.7% | Added |
| FMR LLC | 10,155,254 | $445.6M | 0.03% | +9,267,045+1,043.3% | Added |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −466,271−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −311,500−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −139,298−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −21,984−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,369−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −14,218−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,589−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −6,845−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −6,045−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −4,237−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −2,778−100.0% | Sold out |